Subjects | N = 191 |
---|---|
Demographic characteristics | |
Mean age, years | 70.0 (10.4) |
Ranges: 45-64 years | 29.8% |
65-74 years | 33.5% |
≥ 75 years | 36.6% |
Pensioner | 88.0% |
General comorbidity | |
Number of diagnoses | 7.7 (4.2) |
Charlson Comorbidity Index | 0.6 (0.7) |
RUB (morbidity) | 3.0 (0.7) |
1 (very low) | 4.7% |
2 (low) | 10.1% |
3 (moderate) | 69.2% |
4 (high) | 15.4% |
5 (very high) | 0.6% |
Specific comorbidity | |
Arterial hypertension | 59.8% |
Dyslipidemia | 51.3% |
Cardiovascular event | 32.8% |
Diabetes mellitus | 27.5% |
Active smoker | 22.2% |
Vasculocerebral accident | 22.2% |
Organ failures | 19.6% |
COPD | 18.5% |
Obesity | 18.0% |
Ischemic heart disease | 17.5% |
Depressive syndrome | 14.8% |
Malignant neoplasms | 13.2% |
Alcoholism | 5.3% |
Asthma | 4.8% |
Neuropathies | 4.8% |
Dementias | 2.6% |
Clinical profile (symptoms) | |
Storage | 87.4% |
Voiding | 47.6% |
Post-micturition | 91.1% |
Prostate volume (%) | |
Volume I (<20 ml) | 93.2% |
Volume II (>20-40 ml) | 6.8% |
IPSS scale score | |
Moderate symptoms (8-19 points) | 71.2% |
Severe symptoms (20-35 points) | 28.8% |
Biochemical/anthropometric parameters | |
Systolic blood pressure, mmHg | 129.4 (15.0) |
Diastolic blood pressure, mmHg | 72.5 (10.6) |
Body mass index kg/m2 | 29.0 (4.0) |
Total cholesterol, mg/dL | 186.6 (42.1) |
Serum creatinine, mg/dL | 1.1 (0.4) |
PSA (ng/mL) | 0.9 (0.9) |
Low PSA (<1.5 g/L) | 79.3% |
High PSA (≥1.5 g/L) | 20.7% |